Symbol="BCYC"
AssetType="Common Stock"
Name="Bicycle Therapeutics Ltd"
Description="Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, is developing a class of drugs for diseases that are not served by existing treatments. The company is headquartered in Cambridge, the United Kingdom."
CIK="1761612"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="B900 BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, GB"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="813625000"
EBITDA="-141032000"
PERatio="None"
PEGRatio="None"
BookValue="8.1"
DividendPerShare="0"
DividendYield="0"
EPS="-4.06"
RevenuePerShareTTM="0.753"
ProfitMargin="0"
OperatingMarginTTM="-6.52"
ReturnOnAssetsTTM="-0.204"
ReturnOnEquityTTM="-0.527"
RevenueTTM="22518000"
GrossProfitTTM="-67146000"
DilutedEPSTTM="-4.06"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.603"
AnalystTargetPrice="49"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="61.69"
PriceToBookRatio="3.139"
EVToRevenue="39.3"
EVToEBITDA="-6.12"
Beta="0.72"
num_52WeekHigh="33.49"
num_52WeekLow="18.84"
num_50DayMovingAverage="25.06"
num_200DayMovingAverage="25.18"
SharesOutstanding="36161100"
DividendDate="None"
ExDividendDate="None"
symbol="BCYC"
open="23.20"
high="23.92"
low="22.05"
price="22.50"
volume="1290253.00"
latest_trading_day="2023-08-08"
previous_close="23.37"
change="-0.87"
change_percent="-3.7227%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="48"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="52"
Volume_recent_avg="259454"
Change_recent_avg="-0.02"
Delta_recent_avg="1.34"
Variance_recent_avg="0.67"
Change_ratio_recent_avg="-0.17"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="52"
Aroon_momentum_negative="48"
image_negative_thumbnail_id_1="103"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0073.jpeg"
image_negative_thumbnail_id_2="494"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0111.jpeg"
image_neutral_thumbnail_id_1="554"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_neutral_thumbnail_id_2="553"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_positive_thumbnail_id_1="706"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0002.jpeg"
image_positive_thumbnail_id_2="977"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0139.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1167"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
